isoproterenol has been researched along with 11,12-epoxy-5,8,14-eicosatrienoic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Morgan, JP; Xiao, YF | 1 |
Althurwi, HN; El-Kadi, AO; Elshenawy, OH | 1 |
2 other study(ies) available for isoproterenol and 11,12-epoxy-5,8,14-eicosatrienoic acid
Article | Year |
---|---|
Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; 8,11,14-Eicosatrienoic Acid; Adenosine Triphosphate; Affinity Labels; Animals; Antibodies; Antifungal Agents; Calcium; Calcium Channels; Calcium Channels, L-Type; Cardiotonic Agents; Cell Size; Clotrimazole; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Ventricles; Isoproterenol; Male; Mammals; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Proteins; Myocardium; Phospholipases A; Phospholipases A2; Phosphorylation; Rats; Rats, Wistar; Sodium Cyanide | 1998 |
Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fenofibrate; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hypolipidemic Agents; Isoproterenol; Male; Rats; Rats, Sprague-Dawley | 2014 |